Fine, Richard E.
Gilmore, Richard C.
Dietz, Jill R.
Boolbol, Susan K.
Berry, Michael P.
Han, Linda K.
Kenler, Andrew S.
Sabel, Michael
Tomkovich, Kenneth R.
VanderWalde, Noam A.
Chen, Margaret
Columbus, Karen S.
Curcio, Lisa D.
Feldman, Sheldon M.
Gold, Linsey
Hernandez, Lydia
Manahan, Eric R.
Seedman, Susan A.
Vaidya, Rashmi P.
Sevrukov, Alexander B.
Aoun, Hussein D.
Hicks, Randy D.
Simmons, Rache M.
Funding for this research was provided by:
IceCure Medical Ltd. (https://clinicaltrials.gov/ct2/show/NCT02200705)
Article History
Received: 25 May 2021
Accepted: 7 July 2021
First Online: 15 August 2021
Disclosure
: Andrew Kenler was the medical Director of Icecure for approximately five years and during the time period of this study and was paid for my time as medical Director. That relationship ended approximately one year ago; Kenneth Tomkovich: Stipend received for data entry for patients enrolled in trial to CentraState medical center by IceCure medical. Probes and cryoablation unit provided by IceCure medical to conduct the trial. I received no personal funds for conducting the trial or for the preparation of this manuscript. Neither I nor my medical institution have any relevant conflict of interest in conducting this research; Richard Fine: West Cancer Center & Research Institute (Author's institution) received financial support for conducting the clinical trial. Served on the original scientific advisory board that participated in the Ice3 trial protocol design. Expenses were reimbursed for travel to Chicago, Il in 2014; Margaret Chen-Seetoo: Novian Health—research grant; Theraclion—research grant; Agendia—research grant; PreludeDx—research grant; Susan Seedman profited $280 from prior purchase and sale of publicly traded stock.